Home LiteratureArticle Details
PMID: 6609812 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat.

Endocrinology ·Vol. 114 ·No. 6 ·1984-06-00 ·Pages 2409-11

Rivier C, Vale W

Abstract

The intracerebroventricular administration of 0.15 and 1.5 nmol ovine corticotropin releasing factor ( oCRF ) to freely-moving adult male rats resulted in a dose-related inhibition of spontaneous GH secretion. This inhibition lasted for at least 3 h and was statistically significant at all time points. By contrast, the iv injection of 1.5 nmol oCRF was without effect. These results suggest that CRF can act within the central nervous system to interfere with spontaneous GH secretion.

MeSH Terms
Animals Corticotropin-Releasing Hormone/administration & dosage,pharmacology Dose-Response Relationship, Drug Growth Hormone/metabolism Injections, Intraventricular Kinetics Male Rats Rats, Inbred Strains
Chemicals
Growth Hormone Corticotropin-Releasing Hormone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rivier C
Vale W
Article Info
Journal
Endocrinology
Abbr.
Endocrinology
ISSN
0013-7227
Published
1984-06-00
Pages
2409-11
Language
English
Region
United States
NLM ID
0375040
Subset
IM
Grants
NIAAA NIH HHS · AA-03504 · United States
NIADDK NIH HHS · AM-26741 · United States
NICHD NIH HHS · HD-13527 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com